Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

StressGen acquires rights to gene therapy technology

July 26, 1996

Somatix acquires exclusive license to gene transfer technology

July 26, 1996

Guilford obtains rights to chemotherapy drug delivery system

July 26, 1996

Ribozyme/Alza research collaboration

July 26, 1996

Techniclone International issued European patent for its Modified Antibodies Technology

July 26, 1996

Isis and ProtoGene renew drug discovery collaboration

July 26, 1996

Millennium and Wyeth-Ayerst collaborate on CNS drugs and gene therapies

July 26, 1996

Biogen and Ontogeny sign CNS drug development collaboration

July 26, 1996

Ontogen and Kanebo enter drug development collaboration

July 26, 1996

University of Michigan issued U.S. patent for gene transfer technology

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...